JMR-22143-25888
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 940 / CA
- Registered
- 2021-03-29
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Registered in v-safe
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Survey response — day 0, dose 1MedDRA: Dizziness, Dyspnoea — Feeling: GoodFree text: Feeling faint; shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
- 2021-04-01
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-26
- 2021-05-05
- 2021-05-17
- 2021-07-21
- 2021-10-20
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Feeling faint; shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release